annual

Vantage Concludes a Landmark APAC Gala Dinner in Vietnam, Celebrating Regional Excellence and a Bold Vision for 2026

PORT VILA, Vanuatu, Dec. 15, 2025 /PRNewswire/ -- Vantage proudly concluded its APAC Gala Dinner 2025, marking a milestone moment…

3 weeks ago

CGTN: How does China set tone for economic work in 2026?

BEIJING, Dec. 12, 2025 /PRNewswire/ -- With Chinese leaders gathered in Beijing for the annual Central Economic Work Conference, CGTN published…

4 weeks ago

12TH ANNUAL WINTERNATIONAL EMBASSY SHOWCASE DRAWS 8,000 GUESTS

70 Embassies Unite to Celebrate Global Culture and Traditions at the Ronald Reagan Building and International Trade Center in Washington,…

4 weeks ago

2025 in Review: Celebrating Each Trader’s Unique Journey on Bybit

DUBAI, UAE, Dec. 11, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, is pleased to announce…

4 weeks ago

Latest Data of InnoCares Novel BCL2 Inhibitor Presented at the 67th Annual Meeting of the American Society of Hematology (ASH)

December 08, 2025 21:04 ET  | Source: InnoCare Pharma BEIJING, Dec. 08, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969;…

4 weeks ago

ASH 2025 | Updated Data for Ascentage Pharmas Olverembatinib in Second-Line CML-CP Showing Encouraging Potential for Early-Line Treatment

76.7% complete cytogenetic response rate achieved in patients who failed second-generation TKI first-line therapy Molecular responses continue to deepen with extended…

4 weeks ago

TScan Therapeutics Announces Positive Updated Data from the ALLOHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition

December 06, 2025 17:30 ET  | Source: TScan Therapeutics, Inc. Treatment arm continues to demonstrate favorable relapse-free survival (HR=0.50; p=0.23)…

1 month ago

Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

December 06, 2025 17:30 ET  | Source: Fulcrum Therapeutics, Inc. ― Clear dose-response observed, with a robust and clinically meaningful…

1 month ago

Yidan Prize Foundation connects global insights and local expertise at annual flagship Summit

500 changemakers from over 50 countries stand in solidarity with Hong Kong and co-create paths forward through educationHONG KONG, Dec.…

1 month ago

NYSE Content Advisory: Pre-Market Update + NYSE Hosts 102nd Annual Tree Lighting

NEW YORK, Dec. 4, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

1 month ago